April 26, 2021
LAKEWOOD, Colorado - April 26, 2021 - Terumo Blood and Cell Technologies, a medical technology company specializing in devices that enable blood and cell therapies, announces its participation in the Connecting the Dots video series produced by BBC StoryWorks Commercial Productions and presented by MedTech Europe.
The series highlights patient journeys with Terumo Blood and Cell Technologies' focus on innovative treatments for both sickle cell disease and severe burns.
"Innovation thrives with a holistic approach devoted to patients' unmet needs. We bring together industry, customers, clinicians and patients, using research, science and data to unlock the potential of blood and cells to heal our own bodies," says Antoinette Gawin, President and Chief Executive Officer, Terumo Blood and Cell Technologies.
"We are committed to serving more patients. By seeing through their eyes, we hope to build awareness about how medical technology helps to improve quality of life for patients," says Gawin.
The company is grateful to its customers, the physicians and the patients who felt that same drive to take part in the videos to tell their stories. In this series, you'll meet Bola, a mother of two, whose life has changed with automated red blood cell exchange to help manage her sickle cell disease.
Viewers will also meet Julius, a teenage boy receiving lab-grown human skin to treat his severe burns, under the care of doctors and scientists. The healthcare professionals got a helping hand from automated cell expansion technology made by Terumo Blood and Cell Technologies.
With a heritage in blood collection and processing, the company seeks to evolve as healthcare needs evolve. Its focus is to unlock the potential of blood and cells using the company's experience, skills and technology to automate complex biological processes to help meet unmet medical needs for the many patients like Bola and Julius.
Explore Connecting the Dots here - www.medtechconnectingthedots.com
Terumo Blood and Cell Technologies is a medical technology company. Our products, software and services enable customers to collect and prepare blood and cells to help treat challenging diseases and conditions. Our employees around the world believe in the potential of blood and cells to do even more for patients than they do today. TERUMOBCT.COM
Terumo (TSE: 4543) is a global leader in medical technology and has been committed to "Contributing to Society through Healthcare" for 100 years. Based in Tokyo and operating globally, Terumo employs more than 25,000 associates worldwide to provide innovative medical solutions in more than 160 countries and regions. The company started as a Japanese thermometer manufacturer, and has been supporting healthcare ever since. Now, its extensive business portfolio ranges from vascular intervention and cardio-surgical solutions, blood transfusion and cell therapy technology, to medical products essential for daily clinical practice such as transfusion systems, diabetes care, and peritoneal dialysis treatments. Terumo will further strive to be of value to patients, medical professionals, and society at large.
Corporate Communication Dept., Terumo Corporation
Among the information that Terumo discloses, the forward-looking statements including financial projections are based upon our assumptions using information available to us at the time and are not intended to be guarantees of future events or performance. Accordingly, it should be noted that actual results may differ from those forecasts or projections due to various factors. Factors affecting to actual results include, but are not limited to, changes in economic conditions surrounding Terumo, fluctuations of foreign exchange rates, and state of competition.
Information about products (including products currently in development) included in this material is not intended to constitute an advertisement or medical advice.